We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOYU
12026
PUT
DouYu International Holdings
DOYU
$142M
$18K ﹤0.01%
1,750
-770
-31% -$9.73K
ENIC icon
12027
CALL
Enel Chile
ENIC
$6.27B
$18K ﹤0.01%
13,300
-10,100
-43% -$15K
EVGN icon
12028
CALL
Evogene
EVGN
$9.49M
$18K ﹤0.01%
2,160
-1,720
-44% -$16.6K
FRGT icon
12029
Freight Technologies
FRGT
$1.05M
0
JG
12030
Aurora Mobile
JG
$34.2M
$18K ﹤0.01%
904
-1,109
-55% -$20.9K
NRXP icon
12031
PUT
NRX Pharmaceuticals
NRXP
$140M
$18K ﹤0.01%
2,450
-760
-24% -$5.12K
IMDX
12032
CALL
Insight Molecular Diagnostics
IMDX
$141M
$18K ﹤0.01%
1,245
-2,455
-66% -$42.5K
PYPD icon
12033
PUT
PolyPid
PYPD
$90.9M
$18K ﹤0.01%
510
-197
-28% -$24.4K
PZG icon
12034
Paramount Gold Nevada
PZG
$132M
$18K ﹤0.01%
59,951
-29,530
-33% -$11.7K
STRM
12035
DELISTED
Streamline Health Solutions
STRM
$18K ﹤0.01%
+998
New +$22.4K
USIO icon
12036
Usio Inc
USIO
$78.6M
$18K ﹤0.01%
+13,754
New +$25.2K
VGZ icon
12037
CALL
Vista Gold
VGZ
$337M
$18K ﹤0.01%
33,800
-26,300
-44% -$15.4K
XNET
12038
CALL
Xunlei
XNET
$334M
$18K ﹤0.01%
12,900
-2,600
-17% -$4.11K
QTTB icon
12039
CALL
Q32 Bio
QTTB
$451M
$18K ﹤0.01%
+617
New +$25.2K
NTBL
12040
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$18K ﹤0.01%
3,368
+1,747
+108% +$33.3K
BCEL
12041
PUT
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$18K ﹤0.01%
+11,400
New +$23.4K
LTRPA
12042
CALL
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$18K ﹤0.01%
+16,200
New +$17.1K
EMBKW
12043
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$18K ﹤0.01%
262,292
-427,959
-62% -$43.4K
PLXP
12044
CALL
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$18K ﹤0.01%
27,600
-20,300
-42% -$29.9K
HCARW
12045
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$18K ﹤0.01%
602,061
+2,061
+0.3% +$120
AYTU icon
12046
CALL
AYTU BioPharma
AYTU
$25.5M
$17K ﹤0.01%
4,605
-2,770
-38% -$21K
BBAI icon
12047
CALL
BigBear.ai
BBAI
$1.57B
$17K ﹤0.01%
11,100
-21,200
-66% -$46.6K
CKPT
12048
DELISTED
Checkpoint Therapeutics
CKPT
$17K ﹤0.01%
1,662
-4,267
-72% -$50.8K
FOXO
12049
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$17K ﹤0.01%
+68
New +$116K
FTK icon
12050
CALL
Flotek Industries
FTK
$1.3B
$17K ﹤0.01%
2,800
-4,600
-62% -$29.5K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.